Jahansouz Cyrus, Serrot Federico J, Frohnert Brigitte I, Foncea Rocio E, Dorman Robert B, Slusarek Bridget, Leslie Daniel B, Bernlohr David A, Ikramuddin Sayeed
Department of Surgery, University of Minnesota, 420 Delaware St. SE, MMC 195, Minneapolis, MN, 55455, USA.
Division of Pediatric Endocrinology, Department of Pediatrics, University of Minnesota, 420 Delaware St. SE, MMC 195, Minneapolis, MN, 55455, USA.
Obes Surg. 2015 Dec;25(12):2376-85. doi: 10.1007/s11695-015-1708-5.
Mitochondrial dysfunction in adipose tissue has been implicated as a pathogenic step in the development of type 2 diabetes mellitus (T2DM). In adipose tissue, chronic nutrient overload results in mitochondria driven increased reactive oxygen species (ROS) leading to carbonylation of proteins that impair mitochondrial function and downregulation of key genes linked to mitochondrial biogenesis. In patients with T2DM, Roux-en-Y gastric bypass (RYGB) surgery leads to improvements in glycemic profile prior to significant weight loss. Consequently, we hypothesized that improved glycemia early after RYGB would be paralleled by decreased protein carbonylation and increased expression of genes related to mitochondrial biogenesis in adipose tissue.
To evaluate this hypothesis, 16 obese individuals were studied before and 7-8 days following RYGB and adjustable gastric banding (AGB). Subcutaneous adipose tissue was obtained pre- and post-bariatric surgery as well as from eight healthy, non-obese individual controls.
Prior to surgery, adipose tissue expression of PGC1α, NRF1, Cyt C, and eNOS (but not Tfam) showed significantly lower expression in the obese bariatric surgery group when compared to lean controls (p < 0.05). Following RYGB, but not after AGB, patients showed significant decrease in HOMA-IR, reduction in adipose protein carbonylation, and increased expression of genes linked to mitochondrial biogenesis.
These results suggest that rapid reduction in protein carbonylation and increased mitochondrial biogenesis may explain postoperative metabolic improvements following RYGB.
脂肪组织中的线粒体功能障碍被认为是2型糖尿病(T2DM)发病过程中的一个致病步骤。在脂肪组织中,长期营养过剩会导致线粒体驱动活性氧(ROS)增加,从而导致蛋白质羰基化,损害线粒体功能,并下调与线粒体生物发生相关的关键基因。在T2DM患者中,Roux-en-Y胃旁路术(RYGB)手术在体重显著减轻之前就能改善血糖状况。因此,我们假设RYGB术后早期血糖的改善将伴随着脂肪组织中蛋白质羰基化的减少和与线粒体生物发生相关基因表达的增加。
为了评估这一假设,对16名肥胖个体在RYGB和可调式胃束带术(AGB)术前及术后7 - 8天进行了研究。在减肥手术前后以及从8名健康、非肥胖个体对照中获取皮下脂肪组织。
术前,与瘦对照组相比,肥胖减肥手术组中PGC1α、NRF1、细胞色素C和eNOS(但不包括Tfam)的脂肪组织表达显著降低(p < 0.05)。RYGB术后,但AGB术后未出现,患者的HOMA-IR显著降低,脂肪蛋白羰基化减少,与线粒体生物发生相关的基因表达增加。
这些结果表明,蛋白质羰基化的快速减少和线粒体生物发生的增加可能解释了RYGB术后的代谢改善。